Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-032728·Fortress Biotech, Inc.
Schedule 13D ownership disclosure
FORTRESS BIOTECH INC
Common Stock, $0.001 Par Value · CUSIP: 34960Q307
Event date: 2026-03-18
- Filing-level shares
- 6,917,715.00
- Percent of class
- 20.7%
- Lindsay A. Rosenwald, M.D.Reported CIK 0000941841
Shares: 6,917,715.00 · Class: 20.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-032728
- Form type
- SCHEDULE 13D/A
- Filer
- Fortress Biotech, Inc.
- CIK
- CIK 1429260
- Filed
- Mar 20, 2026
- Reporting period
- Mar 18, 2026
- Description
- Schedule 13D beneficial ownership